The age of striatum determines the pattern and extent of dopaminergic innervation: A nigrostriatal double graft study

Cell Transplantation

Volumn 6, Issue 3, 1997, Pages 287-296

  Strömberg, Ingrid ^a   Björklund, Lars ^a   Förander, Petter ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Graft; Growth pattern; Parkinson's disease; Striatum

Indexed keywords

TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR EYE CHAMBER; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; FEMALE; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; INNERVATION; MESENCEPHALON; NERVE TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030985311     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0963-6897(97)86922-9     Document Type: Article

References (58)

1. Arbrous, D.N.; Choulli, K.; Rouge-Pont, F.; Simon, H.; Le Moal, M.; Herman, J.P. Effects of intracerebral dopaminergic grafts in behavioural deficits induced by neonatal 6-hydroxydopamine lesions of the mesotelencephalic dopaminergic pathway. Neuroscience 54:499-511; 1993.
2. Arbrous, D.N.; Torres, E.M.; Dunnett, S.B. Dopaminergic grafts implanted into the neonatal or adult striatum: Comparative effects on rotation and paw reaching deficits induced by subsequent unilateral nigrostriatal lesions in adulthood. Neuroscience 54:657-668; 1993.
3. Björklund, A.; Stenevi, U. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 177:555-560; 1979.
4. Björklund, L.; Strömberg, I. Dopaminergic innervation of striatal grafts placed into different sites in normal striatum: Differences in the TH-immunoreactive growth pattern. Exp. Brain Res. 113:13-23; 1997.
5. Brundin, P.; Isacson, O.; Gage, F.; Björklund, A. Intrastriatal grafting of dopamine-containing neuronal cell suspensions: Effects of mixing with target or non-target cells. Dev. Brain Res. 24:77-84; 1986.
6. Brundin, P.; Nilsson, O.; Strecker, R.; Lindvall, O.; Astedt, B.; Björklund, A, Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp. Brain Res 65:235-240; 1986.
7. Cadelli, D.S.; Bandtlow, C.E.; Schwab, M.E. Oligodendrocyte- and myelin-associated inhibitors of neurite out-growth: their involvement in the lack of CNS regeneration. Exp. Neurol. 1992:189-192; 1992.
8. Carder, R.K.; Snyder-Keller, A.M.; Lund, R.D. Amphetamine- and stress-induced turning after nigral transplants in neonatally dopamine-depleted rats. Dev. Brain Res. 33: 315-318; 1987.
9. Carvey, P.; Ptak, L.; Kao, L.; Klawans, H. Striatal homogenates from animals chronically treated with haloperidol stimulate dopamine and GABA uptake in cultures of rostral mesencephalic tegmentum. Clin. Neuropharmacol. 12: 425-434; 1989.
10. Chkirate, M.; Vallé, A.; Doucet, G. Host striatal projections into fetal ventral mesencephalic tissue grafted to the striatum of immature or adult rat. Exp. Brain Res. 94:357-362; 1993.
11. Clarke, D.; Brundin, P.; Strecker, R.; Nilsson, O.; Björklund, A.; Lindvall, O. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: Ultrastructural evidence for synapse formation using tyrosine hydroxylase immunocytochemistry. Exp. Brain Res. 73; 115-126; 1988.
12. Coons, A. Fluorescent antibody methods. In: Danielli, J., eds. General cytochemical methods. New York: Academic Press; 1958:399-422.
13. Costanini, L.C.; Vozza, B.M.; Snyder-Keller, A.M. Enhanced efficacy of nigral-striatal cotransplants in bilaterally dopamine-depleted rats: An anatomical and behavioral analysis. Exp. Neurol. 127:219-231; 1994.
14. De Beaurepaire, R.; Freed, W.J. Embryonic substantia nigra grafts innervate embryonic striatal co-grafts in preference to mature host striatum. Exp. Neurol. 95:448-454; 1987.
15. Deckel, A.W.; Moran, T.H.; Robinson, R.G. Behavioral recovery following kainic acid lesions and fetal implants of the striatum occurs independent of dopaminergic mechanisms. Brain Res. 363:383-385; 1986.
16. Deckel, A.W.; Robinson, R.G.; Coyle, J.T.; Sandberg, P.R. Reversal of long-term locomotor abnormalities in the kainic acid model of Huntington's disease by day 18 fetal striatal implants. Eur. J. Pharmacol. 93:287-288; 1983.
17. El Hami, G.; Boutroy, M.; Nehlig, A. Microradioenzymatic determination of regional levels of dopamine and noradrenaline in the developing rat brain. Biogenic Amines 8:115-125; 1991.
18. Freed, W.J.; Perlow, M.J.; Karoum, F.; Seiger, Å.; Olson, L.; Hoffer, B J.; Wyatt, R.J. Restoration of dopaminergic function by grafting fetal rat substantia nigra to the caudate nucleus: Long-term behavioral, biochemical, and histochemical studies. Ann. Neurol. 8:510-519; 1980.
19. Gerfen, C.R. The neostriatal mosaic: Multiple levels of compartmental organization. Trends Neurosci. 15:133-139; 1992.
20. Gerfen, C.R.; Baimbridge, K.G.; Thibault, J. The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems. J. Neurosci. 7: 3935-3944; 1987.
21. Gerfen, C.R.; Herkenham, M.; Thibault, J. The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J. Neurosci. 7: 3915-3034; 1987.
22. Graybiel, A.M. Correspondence between the dopamine islands and striosomes of the mammalian striatum. Neuro-science 13:1157-1187; 1984.
23. Graybiel, A.M.; Liu, F.-C.; Dunnett, S.B. Intrastriatal grafts derived from fetal striatal primordia. I. Phenotypy and modular organization. J. Neurosci. 9:3250-3271; 1989.
24. Graybiel, A.M.; Pickel, V.M.; Joh, T.H.; Reis, D.J.; Ragsdale, C.W., Jr. Direct demonstration of a correspondence between the dopamine islands and acetylcholinesterase patches in the developing striatum. Proc. Natl. Acad. Sci. USA 78:5871-5875; 1981.
25. Graybiel, A.M.; Ragsdale, C.W., Jr. Histochemically distinct compartments in the striatum of human, monkey, and cat demonstrated by acetylcholinesterase staining. Proc. Natl. Acad. Sci. USA 75:5723-5726; 1978.
26. Graybiel, A.M.; Ragsdale, C.W., Jr. Biochemical anatomy of the striatum. In: Emson, P.C. eds. Chem. Neuroanat. New York: Raven Press; 1983:427-504.
27. Herkenham, M.; Pert, C.B. Mosaic distribution of opiate receptors, parafascicular projections and acetylcholinesterase in rat striatum. Nature 291:415-418; 1981.
28. Hudson, J.L.; van Horne, C.G.; Strömberg, I.; Brock, S.; Clayton, J.; Masserano, J.; Hoffer, B.J.; Gerhardt, G.A. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res. 626:167-174; 1993.
29. Isacson, O.; Brundin, P.; Gage, F.H.; Björklund, A. Neutral grafting in a rat model of Huntington's disease: Progressive neurochemical changes after neostriatal ibotenic lesions and striatal tissue grafting. Neuroscience 16:799-817; 1985.
30. Isacson, O.; Dawbarn, D.; Brundin, P.; Gage, F.H.; Emson, P.C.; Björklund, A. Neural grafting in a rat model of Huntington's disease: Striosomal-like organization of striatal grafts as revealed by acetylcholinesterase histochemistry, immunocytochemistry and receptor autoradiography. Neuroscience 22:481-497; 1987.
31. Iversen, S.D.; Dunnett, S.B. Functional organization of striatum as studied with neural grafts. Neuropsychology 28:601-626; 1990.
32. Jaeger, C.B. Axon terminal clustering in nigrostriatal double grafts. Dev. Brain Res. 24:309-314; 1986.
33. Johansson, M.; Friedemann, M.; Hoffer, B.; Strömberg, I. Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic grafts in oculo. Exp. Neurol. 134:25-34; 1995.
34. Johnson, D.C.; de Nogueira-Araujo, G. A simple method of reducing the fading of immunofluorescence during microscopy. J. Immunol. Methods 43:349-350; 1981.
35. Kordower, J.H.; Freeman, T.B.; Snow, B.J.; Vingerhoets, F.J. G.; Mufson, E.J.; Sandberg, P.R.; Hauser, R.A.; Smith, D.A.; Nauert, G.M.; Perl, D.P.; Olanow, C.W. Neuropathological evidence of graft survival and striatal reinnervation after transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332: 1118-1124; 1995.
36. Nikkah, G.; Cunningham, M.G.; Cenci, M.A.; McKay, R.D.; Björklund, A. Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. I. Evidence for anatomical reconstruction of the nigrostriatal pathway. J. Neurosci. 15:3548-3561; 1995.
37. Olson, L.; Seiger, Å.; Fuxe, K. Heterogeneity of striatal and limbic dopamine innervation: Highly fluorescent islands in developing and adult rats. Brain Res. 44:283-288; 1972.
38. Olson, L.; Seiger, Å.; Strömberg, I. Intraocular transplantation in rodents. A detailed account of the procedure and examples of its use in neurobiology with special reference to brain tissue grafting. In: Federoff, S.; Hertz, L. eds. Advances in Cellular Neurobiology, vol 4. New York: Academic; 1983:407-442.
39. Østergaard, K.; Schou, J.P.; Zimmer, J. Rat ventral mesencephalon grown as organotypic slice cultures and cocultured with striatum, hippocampus, and cerebellum. Exp. Brain Res. 82:547-565; 1990.
40. Pakzaban, P.; Deacon, T.W.; Burns, L.H.; Isacson, O. Increased proportion of acetylcholinesterase-rich zones and improve morphological integration in host striatum of fetal grafts derived from the lateral but not the medial ganglionic eminence. Exp. Brain Res. 97:13-22; 1993.
41. Perlow, M.J.; Freed, W.J.; Hoffer, B.J.; Seiger, Å.; Olson, L.; Wyatt, R.J. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204:643-647; 1979.
42. Prochiantz, A.; DiPorzio, U.; Kato, A.; Berger, B.; Glowinski, J. In vitro maturation of mesencephalic dopainergic neurons from mouse embryos is enhances in presence of their striatal target cells. Proc. Natl. Acad. Sci. USA 76: 5387-5391; 1979.
43. Schmidt, R.H.; Björklund, A.; Stenevi, U. Intracerebral grafting of dissociated CNS tissue suspensions: A new approach for neuronal transplantation to deep brain sites. Brain Res. 218:347-356; 1981.
44. Seiger, Å.; Olson, L. Late prenatal ontogeny of central monoamine neurons in the rat: Fluorescence histochemical observations. Z. Anat. Entwickl.-Gesch. 140:281-318; 1973.
45. Sladek, J.R., Jr.; Collier, T.J.; Elsworth, J.D.; Taylor, J.R.; Roth, R.H.; Redmond, D.E., Jr. Can graft-derived neurotrophic activity be used to direct axonal outgrowth of grafted dopamine neurons for circuit reconstruction in primates? Exp. Neurol. 124:134-139; 1993.
46. Strömberg, L; Adams, C.; Bygdeman, M.; Hoffer, B.; Boyson, S.; Humpel, C. Long-term effects of human-to-rat mesencephalic xenografts on rotational behavior, striatal dopamine receptor binding, and mRNA levels. Brain Res. Bull. 38:221-233; 1995.
47. Strömberg, I.; Bickford, P. Reduced aging effects of striatal neuronal discharge rate by aged ventral mesencephalic grafts. Neuroreport 7:693-696; 1996.
48. Strömberg, I.; Bygdeman, M.; Almqvist, P. Target-specific outgrowth from human mesencephalic tissue grafted to cortex or ventricle of immunosuppressed rats. J. Comp. Neurol. 315:445-456; 1992.
49. Strömberg, I.; Bygdeman, M.; Goldstein, M.; Seiger, Å.; Olson, L. Human fetal substantia nigra grafted to the dopamine-deneervated striatum of immunosuppressed rats: Evidence for functional reinnervation. Neurosci. Lett. 71: 271-276; 1986.
50. Strömberg, L; Humpel, C. Expression of BDNF and trkB mRNAs in comparison to dopamine D1 and D2 receptor mRNAs and tyrosine hydroxylase-immunoreactivity in nigrostriatal in oculo co-grafts. Dev. Brain Res. 84:215-224; 1995.
51. Strömberg, L; Johansson, M. Reinitiated growth from mature ventral mesencephalon: An in oculo transplant study of nigrostriatal co-grafts. Exp. Brain Res. 101:73-85; 1994.
52. Tomasowa, Y.; Appel, S. Soluble striatal extracts enhance development of mesencephalic dopaminergic neurons in vitro. Brain Res. 399:111-124; 1986.
53. Ungerstedt, U.; Arbuthnott, G. Quantitative recording of rotational behaviour in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 24: 485-493; 1970.
54. Van Horne, C.; Mahalik, T.; Hoffer, B.; Bygdeman, M.; Almqvist, P.; Stieg, P.; Seiger, Å.; Olson, L.; Strömberg, I. Behavioral and electrophysiological correlates of human mesencephalic dopaminergic xenograft function in the rat striatum. Brain Res. Bull. 25:325-334; 1990.
55. Voorn, P.; Kalsbeek, A.; Jorritsma-Byham, B.; Groenewegen, H. The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat. Neuroscience 25:857-887; 1988.
56. Wictorin, K.; Brundin, P.; Sauer, H.; Lindvall, O.; Björklund, A. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats. J. Comp. Neurol. 323:475-494; 1992.
57. Yurek, D.M.; Collier, T.J.; Sladek, J.R., Jr. Embryonic mesencephalic and striatal co-grafts: Development of grafted dopamine neurons and functional recovery. Exp. Neurol. 109:191-199; 1990.
58. Zhou, F.; Buchwald, N. Connectivities of the striatal grafts in adult rat brain: A rich afference and scant striatonigral efference. Brain Res. 504:15-30; 1989.